ArticleFrontiers in pharmacology2022

Design, synthesis, and biological characterization of a potent STAT3 degrader for the treatment of gastric cancer.

Haobin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.